Evidence map›Paper›PMID 36354728›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers.

Georgios Gaitanis, Athanasia Zampeta, Panagiota Tsintzou, Grigorios Fillis, Konstantinos Seretis, Laurence Feldmeyer, Ioannis Bassukas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Immunotherapy in Basal Cell Carcinoma.Journal of clinical medicine · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Georgios GaitanisDepartment of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45100 Ioannina, Greece.ORCID 0000-0001-5482-1304
Athanasia ZampetaDepartment of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45100 Ioannina, Greece.
Panagiota TsintzouDepartment of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45100 Ioannina, Greece.
Grigorios FillisDELC Clinic, 2502 Biel/Bienne, Switzerland.
Konstantinos SeretisDepartment of Plastic and Reconstructive Surgery, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45100 Ioannina, Greece.ORCID 0000-0002-1844-1264
Laurence FeldmeyerDepartment of Dermatology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Ioannis BassukasDepartment of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45100 Ioannina, Greece.ORCID 0000-0002-0252-8314
University of Ioannina · GRSpitalzentrum Centre hospitalier Biel- Bienne · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this retrospective, chart review study, we evaluated the feasibility of immunocryosurgery in facial, non-superficial basal cell carcinomas (BCC) that had relapsed after standard surgery. Inclusion criteria were (a) 'biopsy confirmed relapse of facial BCC', (b) known 'calendar year of surgical excision(s)', and (c) 'relapse within 10 years after the last surgical excision'. Tumors treated from 1 January 2011 to 31 December 2020 with a standard 5-week immunocryosurgery cycle (daily imiquimod application for 5 weeks and a cryosurgery session at day 14) were included. Descriptive statistics, Kaplan-Meier method, and Cox proportional hazards model were calculated with significance at

Indexed as

Basal Cell CarcinomaSkin NeoplasmsFeasibility StudiesHumansNeoplasm Recurrence, LocalRetrospective Studiesbasal cell carcinomacryosurgeryimiquimodimmunocryosurgery

Identifiers

PMID36354728
PMCPMC9688977
OpenAlexW4308512102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.